[Dual regulation by delta opioid receptor agonists on the delayed rectified potassium channels in NG108-15 cells]

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Apr;25(2):164-7.
[Article in Chinese]

Abstract

Objective: To investigate the dual effects by the delta opioid receptor agonists DPDPE on the delayed rectified potassium channels in NG108-15 cells.

Methods: A series of outward currents were evoked in NG108-15 cells by depolarizing voltage from -50 mV to +80 mV at holding potential of -90 mV. These currents were delayed rectified potassium currents. Relatively selected delta opioid receptor agonists DPDPE of higher and lower concentrations were used to modulate the delayed rectified K+ current in NG108-15 cells. Opioid receptor antagonist Naloxone (NAL) and relatively selected delta opioid receptor antagonist Naltrindole (NTI) were used in the present experiments for the characterization of the actions of opioid receptors.

Results: The relatively higher concentrations of delta opioid receptor agonist DPDPE (> or = 10(-6) mol/L) significantly increased the amplitude of the delayed rectified K+ current. On the contrary, the relatively lower concentrations of DPDPE (< or = 10(-12) mol/L) decreased the amplitude of the delayed rectified K+ current (P < 0.05). Furthermore both the increase and decrease were time-dependent.

Conclusions: delta opioid receptor agonist has dual regulatory effects on the delayed rectified potassium channels in NG108-15 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / metabolism
  • Enkephalin, D-Penicillamine (2,5)- / pharmacology*
  • Glioma / metabolism
  • Glioma / pathology
  • Hybrid Cells / metabolism
  • Mice
  • Naloxone / pharmacology
  • Naltrexone / analogs & derivatives*
  • Naltrexone / pharmacology
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Patch-Clamp Techniques
  • Potassium Channels, Inwardly Rectifying / drug effects*
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Rats
  • Receptors, Opioid, delta / agonists*
  • Tumor Cells, Cultured

Substances

  • Potassium Channels, Inwardly Rectifying
  • Receptors, Opioid, delta
  • Naloxone
  • Naltrexone
  • Enkephalin, D-Penicillamine (2,5)-
  • naltrindole